Online Pressekonferenz am 16. September 2024 Anlässlich des Welttags der Patientensicherheit laden wir alle Interessierten zu unserer hybriden Pressekonferenz am 16. September 2024 von 11.00 bis 12.00 Uhr herzlich ein. Gemeinsam diskutieren wir…
Archiv
Die Deutsche Parkinson Vereinigung stellt sich neu auf Aufbruchstimmung bei der Deutschen Parkinson Vereinigung (dPV) e. V.: Seit August 2023 ist ein komplett ausgewechselter Bundesvorstand im Amt. Die neue Führungsspitze arbeitet daran, die…
Kreativität mit Parkinson Das Zentrum für Parkinson und Bewegungsstörung der Universitätsklinik für Neurologie Bern hat unter der Leitung von Dr. med. Ines Debove gemeinsam mit der Filmemacherin Bettina Rotzetter einen Parkinsonbetroffenen porträtiert. Dank…
AskBio’s investigational gene therapy AB-1005 has been granted fast-track designation for Parkinson’s disease by the U.S. Food and Drug Administration (FDA), and innovation passport designation by the regulatory agency in the U.K. These…
It’s that time of year again: time for our annual Walk for Parkinson’s. I hate asking people for money, even for such a worthwhile cause as our local Parkinson’s Society here in Ontario,…
The first three Parkinson’s disease patients who received a low dose of TED-A9, an investigational stem cell-based therapy being developed by S.Biomedics, saw reduced motor symptoms after a year without any reported side…
Scientists have discovered a new regulator — called NHR-49 — that may shed light and open potential new therapeutic avenues to prevent the formation of toxic protein clumps, a hallmark of aging-related diseases,…
Anew Medical said it will advance clinical development of its Klotho gene therapy program to prevent or stop the progression of neurodegenerative diseases, including Parkinson’s disease. Initial data suggest that maintaining high levels…
By prohibiting the Activin A protein from functioning, researchers were able to halt the development of dyskinesia symptoms and effectively erase the brain’s ‚bad memory‘ response to L-DOPA treatments.
Scientists have developed a simple blood test that uses artificial intelligence (AI) to predict Parkinson’s up to seven years before the onset of symptoms.